The stock price of Eli Lilly has seen a rise of nearly 10% over the last twenty-one trading days, and it is also up a solid 55% year-to-date. The company recently announced its Q2 results, with revenues topping but earnings falling short of the street estimates. Eli Lilly garnered $6.7 billion...
The stock price of Eli Lilly has seen a rise of nearly 10% over the last twenty-one trading days, and it is also up a solid 55% year-to-date. The company recently announced its Q2 results, with revenues topping but earnings falling short of the street estimates. Eli Lilly garnered $6.7 billion...
Share this Article
Recommended